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Abstract Regions of genomic DNA encoding putative aspartic 
proteinase domains were amplified by PCR from the bacterial 
species, Escherichia coli and Haemophilus influenzae. Expres-
sion of each of these DNA fragments resulted in the accumula-
tion of the corresponding recombinant proteins in insoluble 
aggregates. Each recombinant protein was solubilised, refolded 
and shown to be able to cleave synthetic peptides that have been 
extensively used previously as substrates for aspartic proteinases 
of vertebrate, fungal and retroviral origin. Each activity was 
completely blocked by the diagnostic aspartic proteinase 
inhibitor, acetyl-pepstatin. This is thus the first report demon-
strating unequivocally that aspartic proteinases may be present 
in bacteria. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The active site cleft of aspartic proteinases lies between two 
domains, each of which contributes an aspartic acid residue to 
the catalytic mechanism [1]. Each aspartic acid residue is 
found in the characteristic sequence motif ~ Hydrophob ic -
Hydrophobic-Asp-Thr /Ser-Gly ~ which, together with a fur-
ther ~ Hydrophobic-Hydrophobic-Gly ~ sequence motif 
forms a structural feature known as a psi-loop [2]. In some 
enzymes, the two domains are contained within a single poly-
peptide chain so that each of the two motifs occurs twice 
within the molecule [3]. In contrast, some aspartic proteinases 
are homodimers consisting of identical monomers and in these 
cases, the ~ Hydrophobic-Hydrophobic-Asp-Thr /Ser -Gly ~ 
and ~ Hydrophobic-Hydrophobic-Gly ~ motifs are encoded 
only once within the corresponding gene [2]. This is the case, 
for example, with aspartic proteinases encoded within viruses 
which infect vertebrates, e.g. HIV-1 , [4] and plants, e.g. cocao 
swollen shoot virus [5]. Aspartic proteinases have been found 
in a wide variety of organisms, ranging from viruses, fungi 
and parasites to plants, fishes and higher vertebrates including 
man [6]. Hitherto, however, it has been widely held that bac-
teria do not produce aspartic proteinases [7]. 
With the advent of genome sequencing projects, it is now 
possible to scrutinise bacterial genomes deposited in public 
domain databases for the occurrence together of the two hall-
marks of aspartic proteinases, i.e. the ~ Hydrophobic-Hydro-
phobic-Asp-Thr /Ser-Gly ~ and ~ Hydrophobic-Hydropho-
bic-Gly ~ motifs. In this report, we show that such 
information is encoded within the genomes of two bacteria, 
Escherichia coli and Haemophilus influenzae and show that the 
»Corresponding author. Fax: (44) 1222-874116. 
E-mail: HILLJ@Cardiff.ac.uk 
recombinant proteins resulting from expression of each of 
these D N A regions, are active aspartic proteinases. 
2. Materials and methods 
Genomic DNA prepared from H. influenzae and E. coli cells [8] was 
used as template for PCR. Oligonucleotide primers (incorporating 
restriction sites for BamHl and HindUl and stop codons) were de-
signed to amplify each region of DNA encoding the putative aspartic 
proteinases: 
5'-GG ATC CGA TTT ACG ATT TTG H. inf forward primer 
TTG TTT AAA C-3 ' 
5'-AA AGC TTA AGA ATG GGA ATT H. inf reverse primer 
ATC AGC TC-3' 
5'-CG GAT CCG AGG TCT AAA CCG E. coli forward primer 
TGG TCG T-3 ' 
5'-GA AGC TTA CAC CGA GAT AAT E. coli reverse primer 
GGT TTC C-3 ' 
Each PCR product generated was cloned into the pGem-T vector 
system (Promega, Southampton, UK) and its nucleotide sequence 
was determined using a Pharmacia ALF automated sequencer. Both 
sequences were identical to those deposited in the databases. Each 
DNA fragment was excised with BamHl and HindlH and cloned 
into the T7 expression vector pET23c (AMS Biotech., Witney, 
Oxon, UK) that had been cut with the same enzymes. 
Expression of the putative aspartic proteinases was carried out in E. 
coli strain BL21(DE3)pLysS as described previously [9]. The induc-
tions were initiated by the addition of 1 mM IPTG and the cells were 
harvested after 2 h. Repeated freeze-thaw cycles followed by sonica-
tion were used to ensure complete cell lysis. After centrifugation 
(7000 X g for 30 min), the respective cell pellets were washed in buffer 
A (100 mM Tris-HCl, pH 11.0). The insoluble material from each 
induction was then dissolved in buffer B (6 M urea, 100 mM Tris-
HCl, pH 8.0, 1 mM glycine, 1 mM EDTA). 
The two recombinant polypeptides produced were refolded under 
differing conditions. The H. influenzae protein in buffer B was sub-
jected to a rapid dilution in buffer C (10 mM Tris-HCl, pH 8.0) to a 
final protein concentration of 5 ug/ml. The E. coli protein in buffer B 
was subjected to a rapid dilution in buffer D (100 mM Tris-HCl, pH 
8.0, 0.3 mM GSH, 3 mM GSSG) also to a final protein concentration 
of 5 ug/ml. Both of the resultant solutions were stirred at 20°C for 16 
h, re-concentrated using a Filtron Ultrasette 3 kDa cut-off, tangential-
flow concentrator (Flowgen Instruments Ltd., Sittingbourne, Kent, 
UK) and finally in an Amicon stirred cell concentrator (Amicon, 
Gloucestershire, UK) to final protein concentrations of 1 mg/ml. 
The proteolytic activity in each dilute and concentrated protein 
fraction was assessed using synthetic peptides as substrates: 
Ac-Tyr-Arg-Ala-Arg-Val- (for E. coli) 
Phe*NPhe-Val-Arg-Ala-Ala-Lys 
Lys-Pro-Ile-Glu-Phe*NPhe-Arg- (for H. influenzae, where 
Leu NPhe =p-nitrophenylalanine). 
The assays were carried out at 37°C in a standard assay buffer (100 
mM sodium acetate, pH 4.7, 4 mM EDTA) and the reaction products 
were analysed by reverse-phase FPLC. The effect of a diagnostic as-
partic proteinase inhibitor was investigated by the addition of acetyl 
pepstatin to a final concentration of 1 uM. 
SDS-PAGE was carried out on 15% polyacrylamide gels as de-
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 5 4 7 - 4 
358 / . Hill, L.H. PhylipIFEBS Letters 409 (1997) 357-360 
scribed by Laemmli [10]. Bands corresponding to the expected sizes of 
the expressed proteins were blotted onto PVDF membranes and 
loaded into an Applied Biosystems ABI 470 A sequenator for N-
terminal sequence analysis by Edman Degradation. 
E.coli 
H.inf. 
E.coli 
H.inf. 
- G L N R G R S M D Q I N - - - - - - D T L V S 
- F T I L L F K Q L S K P T W Q V D T L D V 
S I K I I A M M L L I I G G G G A F K Q V L V 
G Q - - - G L A T L I V K N G - - - K G I L Y 
3. Results and discusion 
E.coli 
H. inf. 
D S G V D K Y I A S M M H E T N I S P L L M A 
D T G S S W R G C S M A - E L E I L P Y L Q R 
Both of the bacterial sequence entries (Gene Bank accession 
numbers ECOUW67 and L20805 for E. coli and H. influenzae, 
respectively) in the databases encode only one copy of 
the ~ Hydrophobic-Hydrophobic-Asp-Thr/Ser-Gly ~ and 
~ Hydrophobic-Hydrophobic-Gly <~ motifs. On this basis, 
it would be necessary for these putative bacterial aspartic 
proteinases to exist as homodimers in order to generate cata-
lytic activity, as has been described in detail for the viral 
aspartic proteinases [11]. In retroviral proteinases, the active 
site aspartic acid residue is located at approximately residue 
25 in the protein sequence (depending on the virus) with the 
glycine of the ~ Hydrophobic-Hydrophobic-Gly ~ in the 
thread of the psi-loop located a further ~ 60 residues down-
stream at position ~ 8 6 [12]. Inspection of the E. coli and H. 
influenzae protein sequences (Fig. 1) shows that approximately 
60 residues are interposed also between these two motifs in the 
bacterial proteins (Fig. 2). It was thus possible to estimate a 
minimal length for each bacterial (putative) aspartic protein-
ase domain by comparison with the known cleavage junctions 
at the N- and C-termini of retroviral aspartic proteinases 
which consist of 100-130 residues [12]. On this basis, specific 
primers were designed to enable bacterial DNA fragments to 
be amplified that were longer than this minimal estimate. For 
E. coli, a 444 bp fragment was amplified and cloned which 
encoded the 142 amino acids shown in the sequence in Fig. 1 
while a 435 bp fragment (encoding 139 residues) was derived 
in parallel from H. influenzae. 
Overexpression of each of these DNA fragments in E. coli 
resulted in the accumulation of each recombinant protein in 
the form of insoluble aggregates. Yields were estimated to be 
20 and 50 mg/1 of culture, respectively, for the recombinant E. 
coli and H. influenzae proteins. Each protein was detected by 
Western blotting using a monoclonal antibody against the 13 
N-terminal amino acids (T7 tag) encoded by the expression 
vector. The protein aggregates were solubilised using a buffer 
containing 6 M urea (see Section 2). Aliquots were subjected 
to SDS-PAGE on a 15% gel followed by blotting of the ap-
propriate recombinant protein band onto PVDF membrane 
for sequencing by Edman degradation. The sequences ob-
tained confirmed that the T7 tag had been retained at the 
N-terminus of each recombinant protein : 
E. coli: Ala-Ser-Met ~ tag ~ Gly-Leu-Asn-Arg-Gly-Arg-
T7 Ser~ 
H. influenzae: Ala-Ser-Met~ tag~Phe-Thr-Ile-Leu-Leu-Phe-
T7 Lys~ 
Comparison of these sequences with those in Fig. 1 indi-
cates that no proteolytic processing had taken place at the N-
terminus of either recombinant protein while it was accumu-
lating (in an insoluble form) in the heterologous cells. 
Each of the 6 M urea solutions containing the respective 
recombinant proteins was used in a variety of experiments 
that examined a number of different protocols in attempts 
to refold each protein. Eventually, different protocols were 
E.coli 
H.inf. 
W S I A A V L - R I I A L G S A T V A A I T A 
E G I - - V L E K L I L - - S H D D N D - H A 
E.coli G G I A A - - - - - P - - - L I A T T - G V S 
H.inf. G G A S T I L K A Y P N V E L I T P S R K N Y 
E.coli 
H.inf. 
P E L M V I - - A V G S G S V I - F S H V N D 
G E N Y R T F C T~À" G R D W H W Q G T , H F Q -
E.coli P G F W L F K E Y F N L - T I G E T I K 5 W S M -
H.inf. - - - I L S P H - - N V A T R A D N - - S H S -
Fig. 1. Amino acid sequences of the putative aspartic proteinase do-
mains from E. coli and H. influenzae. The ~ Asp-Thr/Ser-Gly ~ 
motifs are shown in bold type and the ~ Hydrophobic-Hydropho-
bic-Gly ~ motif of the psi-loop is underlined. Gaps (indicated by a 
hyphen) are inserted to maximise the apparent similarity. 
adapted for the two proteins. For the E. coli protein, it was 
necessary to include a combination of reduced and oxidised 
glutathione in the refolding buffer to prevent the reformation 
of insoluble aggregates [13]. In both cases, an extensive dilu-
tion (detailed in Section 2) step was employed. When aliquots 
of each of the recombinant proteins was assessed for ability to 
cleave synthetic peptides, no activity was detected at this di-
lution stage (final protein concentration = 5 ug/ml; see Section 
2). Each dilute solution was concentrated by approximately 
2000-fold and then assessed for activity again since it has been 
demonstrated frequently that the activity of homodimeric as-
partic proteinases such as HIV proteinase are enzyme concen-
tration dependent [14,15]. Since the purpose of these investi-
gations was to determine whether the two bacterial proteins 
were catalytically active as aspartic proteinases, two synthetic 
chromogenic peptides were utilised in these assays which have 
been widely used in many previous studies to characterise 
retroviral [16] and vertebrate/fungal aspartic protein-
ases [17,18]. Consequently, the activity of the putative homo-
dimeric enzyme from E. coli was tested towards the pseudo-
symmetrical peptide Ac-Tyr-Arg-Ala-Arg-Val-Phe*NPhe-
Val-Arg-Ala-AIa-Lys which has been demonstrated to be 
among the best substrates for symmetrical homodimeric en-
zymes, e.g. HIV proteinase [19]. Indeed this peptide was 
cleaved readily by the recombinant protein from E. coli 
(Fig. 3) and the cleaved products were eluted from the re-
verse-phase column in identical positions to the well-charac-
terised products resulting from cleavage of this peptide sub-
strate by HIV proteinase [19]. Thus, it is clear that the 
recombinant E. coli protein was attacking this substrate at 
the intended scissile peptide bond, i.e. between the Phe and 
/»-nitrophenylalanine residues. 
The activity of the H. influenzae recombinant protein was 
assessed using a peptide which has been demonstrated to be 
among the best substrates for archetypal aspartic proteinases, 
e.g. cathepsin E [17] and cathepsin D [18]. This peptide Lys-
Pro-Ile-Glu-Phe*NPhe-Arg-Leu was completely cleaved by 
the H. influenzae protein at the intended scissile peptide bond 
(Fig. 3b) and the kinetic parameters estimated by the FPLC 
assay for this reaction at pH 4.7 were Km = 105 ± 14 uM and 
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Vm = 100 ±2 nmol/min/mg protein. In contrast, little or no 
activity was detected towards the substrate Ac-Tyr-Arg-Ala-
Arg-Val-Phe*NPhe-Val-Arg-Ala-Ala-Lys. Similarly, the re-
combinant E. coli protein had little ability to cleave the sub-
strate Lys-Pro-Ile-Glu-Phe*NPhe-Arg-Leu. This suggests 
that the two bacterial enzymes differ in their substrate specif-
icity, one preferring a retroviral type of substrate while the 
other prefers an archetypal type of substrate. 
The cleavage of the retroviral proteinase substrate by the 
recombinant E. coli protein and the archetypal proteinase 
substrate by the H. influenzae protein were both completely 
prevented when the diagnostic inhibitor of aspartic pro-
teinases, acetyl pepstatin [20] was included in the assay buffer 
at a final concentration of 100 nM (Fig. 3, bottom two pan-
els). 
This unequivocal demonstration of proteolytic activity in-
trinsic to each bacterial protein was further confirmed by 
SDS-PAGE analysis of each concentrated preparation after 
the the dilution and refolding steps. Less than 5% of the 
recombinant protein that had been present prior to these steps 
was recovered in the concentrated material in each case. Thus, 
it would appear that a large proportion of each recombinant 
bacterial protein was still misfolded and was digested by the 
( < 5%) of the protein which had folded properly to generate 
active proteinase. Autolysis of each correctly folded, active 
bacterial proteinase may also have taken place, just as has 
been observed with dimeric aspartic proteinases such as HIV 
proteinase which are known to undergo autolysis initially at 
specific sites within the proteinase molecule itself, but eventu-
ally leading to complete digestion of the enzyme [21]. Further 
experiments are now in progress to optimise the refolding 
conditions yet more, together with production of each re-
combinant bacterial protein on a larger scale. These should 
enable the purification of sufficient amounts of each bacterial 
proteinase to permit a more-detailed characterisation of each 
enzyme, including crystallisation trials, to be undertaken. 
Nevertheless this is the first report identifying a 'typical 
aspartic proteinase' activity in species of bacteria. Until 
now, acid proteinase activity in bacteria has either been at-
tributed to proteins that share no primary sequence homology 
whatsoever to known aspartic proteinases [22] or to protein-
ases with unknown primary amino acid sequences that are 
not inhibited by pepstatin [23]. Aspartic proteinases encoded 
by retroviruses, pararetroviruses [24] and retrotransposons 
[25] are known to be dimeric whereas eukaryotic aspartic pro-
teinases are predominantly monomeric and are believed to 
have evolved from a gene duplication with fusion event that 
places two copies each of the =Hydrophobic-Hydrophobic-
Asp-Ser/Thr-Gly ~ and ~ Hydrophobic-Hydrophobic-
Gly ~ motifs into each gene [3]. Since both of the bacterial 
HIV: 
E.coli: 
H.inf: 
Fig. 2. The relative locations of the two sequence motifs in HIV 
proteinase and the putative aspartic proteinase domains from E. coli 
and H. influenzae. The number of residues adjacent to and in the se-
quence intervening between the ~ Hydrophobic-Hydrophobic-Asp-
Thr/Ser-Gly~ and ~ Hydrophobic-Hydrophobic-Gly ~ motifs are 
indicated within each solid block. 
(a) 
N 
1 21 
| 38 
1 36 
f~L-L-D-T-&j 
[L-V-D-S-O] 
|-L-Y-D-T-o| 
56 
62 
68 
C 
|-i-i-o-1 13 | 
[~A-V-O| 34 
pT-A-G-l 2 7 
Fig. 3. Cleavage of peptide substrates by recombinant E. coli and 
H. influenzae proteins and the effect of pepstatm. The synthetic pep-
tides : Ac-Tyr-Arg-Ala-Arg-Val-Phe*NPhe-Val-Arg-Ala-Ala-Lys 
(left panels) and Lys-Pro-Tle-Glu-Phe*NPhe-Arg-Leu (right pan-
els) were incubated in 100 mM sodium acetate buffer, pH 4.7, at 
37°C (a) alone or with recombinant E. coli (left) or H. influenzae 
proteins (right) in the absence (b) or presence (c) of acetyl pepstatin 
(100 nM). 
sequences contain only one copy of each motif, dimeric bac-
terial aspartic proteinases may represent an important stage in 
the evolutionary pathway of this family of enzymes. The two 
DNA fragments that were amplified in this study were them-
selves only segments of larger open reading frames (1.3 and 
2.4 kb, respectively) in the deposited E. coli and H. influenzae 
sequences. In these original depositions, it was suggested that 
these larger genes both encoded membrane-spanning trans-
porter proteins; for gluconate in the case of E. coli and 
DNA in the H. influenzae case [26] but no functional evidence 
in support of this has appeared. Thus, it may be that the 
aspartic proteinase domain located towards the C-terminal 
end of the protein encoded by each of these larger genes 
may be part of of a multifunctional protein and that dimer-
isation is required not only to generate proteolytic activity but 
also may be intrinsic to the operation of the respective mem-
brane-spanning transporters. Further work will be necessary 
to investigate this and to establish whether (and where) the 
proteinase domain processes itself out from the multifunction-
al precursor protein, perhaps in a parallel manner to that 
authenticated so meticulously for HIV polyprotein processing 
[27]. The significance of such events to bacterial viability also 
requires investigation, with the incentive of offering potential 
new antibacterial drug targets. Bacterial infections are becom-
ing an increasingly serious problem with the increased inci-
dence of bacterial meningitis and E. coli food poisoning and 
such problems are exacerbated by the decreasing effectiveness 
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of conventional antibiotics due to bacterial resistance. The 
discovery of bacterial members of a widely investigated en-
zyme family may offer tempting new drug targets. 
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